Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SOLARA ACTIVE PHARMA SCIENCES LIMITED Major Shareholding Notification 2020

Jul 1, 2020

61842_rns_2020-07-01_c5fdc111-cd20-40a4-a1e1-7806019ae9e1.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Disclosure under Regulation 30(1) and 30(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 as on 31[st] March 2020

Part-A- Details of Shareholding

==> picture [510 x 463] intentionally omitted <==

----- Start of picture text -----

1. Name of the Target Company (TC) Solara Active Pharma Sciences Limited
CIN:- L24230MH2017PLC291636
2. Name(s) of the Stock Exchange(s) where the National Stock Exchange of India Limited
shares of the TC are listed
BSE Limited
3. Particulars of the shareholder(s):
a. Name of person(s) together with Person Acting
in Concert (PAC) whose total holding (including
that in the form of shares, warrants, convertible
List Enclosed
securities and any other instrument that would
entitle the holder to receive shares in the TC) is
more than 25% of the voting rights of the TC.
or
b. Name(s) of promoter(s), member of the
promoter group and PAC with him.
4. Particulars of the shareholding of person(s) Number of % w.r.t. total % of total
mentioned at (3) above shares share /voting diluted
capital share/voting
wherever capital of TC
applicable ()
As on March 31 [st] March 2020, holding of:
a) Equity Shares with face value of Rs 10/- each 1,12,47,270 41.88 31.72
b) Voting Rights (otherwise than by shares) - - -
c) Warrants 46,00,000 NA 12.97
d) Convertible Securities - - -
e) Any other instrument that would entitle the - - -
holder to receive shares in the TC.
Total 1,58,47,270 NA 44.70
----- End of picture text -----*

Place: Bengaluru Date: 20-04-2020

For and on behalf of Promoters Kannan P R Authorised Signatory

and promoter group of Solara Active Pharma Sciences Limited

This PDF document was edited with Icecream PDF Editor . Upgrade to PRO to remove watermark.

Part-B**

Name of the Target Company: Solara Active Pharma Sciences Limited

==> picture [497 x 463] intentionally omitted <==

----- Start of picture text -----

S Name(s) of the person and Persons Acting in Concert Whether the person PAN of the
No (PAC) with the person belongs to person and
Promoter/Promoter group PACs
1 MR. ARUN KUMAR PILLAI Promoter AFBPP0461L
2 MR. K R RAVISHANKAR Promoter ADAPR6016N
3 M/s PRONOMZ VENTURES LLP Promoter AAMFP6800H
4 MS. YALAVARTHY USHA RANI Promoter Group AAKPU4778P
5 MS. SAJITHA PILLAI Promoter Group AAOPP8082D
6 MS. K R LAKSHMI Promoter Group ACRPL9956D
7 MS. RAJITHA GOPALAKRISHNAN Promoter Group ADEPG1876F
8 ADHPP2165P
MR. PADMAKUMAR KARUNAKARAN PILLAI [Promoter Group]
9 MS. RAJESWARI AMMA Promoter Group AECPR7026R
10 MS. VINEETHA MOHANAKUMAR PILLAI Promoter Group AEUPV7329F
11 MS. DEEPA ARUN KUMAR Promoter Group AFUPK7866D
12 MS. HEMALATHA PILLAI Promoter Group AHDPP9420B
13 MR. ADITYA ARUN KUMAR Promoter Group AVVPK5420G
14 MS. TARINI ARUN KUMAR Promoter Group BMSPK2932C
15 M/S. SEQUENT SCIENTIFIC LIMITED Promoter Group AAACV1501G
16 M/S. CHAYADEEP PROPERTIES PVT LTD Promoter Group AACCC3489Q
17 M/S. KARUNA VENTURES PRIVATE LIMITED Promoter Group AADCK7179G
18 M/S. CHAYADEEP VENTURES LLP Promoter Group AAGFC8406J
19 M/S. TRIUMPH VENTURE HOLDINGS LLP Promoter Group AAGFT3659Q
20 M/S. AGNUS HOLDINGS PVT LTD Promoter Group AAHCS6660A
21 M/S. DEVICAM CAPITAL LLP Promoter Group AAJFD9957E
22 M/S. KARUNA BUSINESS SOLUTIONS LLP Promoter Group AAOFK7620G
23 M/S. AGNUS CAPITAL LLP Promoter Group AARFA9302J
24 M/s KARUNA HEALTHCARE PRIVATE LIMITED Promoter Group AAGCK4475L
----- End of picture text -----

For and on behalf of Promoters and promoter group of Solara Active Pharma Sciences Limited

Place: Bengaluru Kannan P R Date: 20-04-2020 Authorised Signatory

Note:

  1. In case of promoter(s) making disclosure under regulation 30(2), no additional disclosure under regulation 30(1) is required.

(*) Diluted share/voting capital means the total number of shares in the TC assuming full conversion of the outstanding convertible securities/warrants into equity shares of the TC.

(**) Part-B shall be disclosed to the Stock Exchanges but shall not be disseminated.

This PDF document was edited with Icecream PDF Editor . Upgrade to PRO to remove watermark.